Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

OBJECTIVE: To compare the efficacy of adjuvant chemotherapy with six or eight cycles of S-1 plus oxaliplatin (SOX) or Capecitabine plus oxaliplatin (XELOX) after D2 resection of GC. DESIGN AND PARTICIPANTS: We collected 470 cases of patients with TNM stage II and III GC who underwent D2 gastrectomy...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Yu, Yuanyuan, Zhang, Zicheng, Meng, Qianhao, Ma, Yue, Fan, Xiaona, Sun, Jie, Wang, Guangyu
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181140/
https://ncbi.nlm.nih.gov/pubmed/34109131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.684627
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы